Get the Stockscreener App
0.3666
2.38%
0.0089
After Hours:
.37
0.0034
+0.93%
Cosmos Health Inc stock is traded at $0.3666, with a volume of 1.70M.
It is up +2.38% in the last 24 hours and up +12.26% over the past month.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
See More
Previous Close:
$0.3577
Open:
$0.358
24h Volume:
1.70M
Relative Volume:
2.00
Market Cap:
$19.18M
Revenue:
$65.27M
Net Income/Loss:
$-19.15M
P/E Ratio:
-0.5905
EPS:
-0.6208
Net Cash Flow:
$-12.43M
1W Performance:
+2.58%
1M Performance:
+12.26%
6M Performance:
-59.32%
1Y Performance:
-13.71%
1-Day Range:
$0.3501
$0.40
1-Week Range:
$0.345
$0.40
52-Week Range:
$0.2805
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3666 | 19.38M | 65.27M | -19.15M | -12.43M | -0.6208 |
MCK
Mckesson Corp
|
815.20 | 102.28B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
308.01 | 60.69B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
192.88 | 48.38B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
74.59 | 8.73B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.19 | 2.00B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health projects Cur18 to generate $2.5M in U.S. revenue - Investing.com Canada
Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months - Weatherford Democrat
A turmeric supplement is central to Cosmos Health's $2.5M U.S. sales bet - Stock Titan
Cosmos Health (COSM) price target increased by 50.00% to 4.59 - MSN
Cosmos Health Continues US Expansion with Q2 Launch of Cur18a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health - ACCESS Newswire
Cosmos Health (COSM) holder reports 4.14M shares, 8.15% stake in amendment - Stock Titan
Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Produ - Palestineherald.com
73.5M Cosmos Health shares registered for resale (NASDAQ: COSM) - Stock Titan
Cosmos Health (COSM) Year-Ahead Outlook | Q4 2025: Below ExpectationsAcquisition - Xã Vĩnh Công
Is Cosmos Health (COSM) stock still a good play today | Q4 2025: Profit DisappointsReal-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Cosmos Health (COSM) Stock: Consolidation Phase Insight (Smart Money Flows) 2026-04-22Quantitative Analysis - Cổng thông tin điện tử tỉnh Lào Cai
COSM Stock Price, Quote & Chart | COSMOS HEALTH INC (NASDAQ:COSM) - ChartMill
Cosmos Health Introduces the "18 Series" in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Finviz
This supplement line only launches products at exact clinical-trial doses - Stock Titan
Cosmos Health to begin Liv18 liver supplement production in April By Investing.com - Investing.com Australia
COSM earnings show rapid revenue growth - MSN
Cosmos Health to begin Liv18 liver supplement production in April - Investing.com
A U.S.-made liver supplement is central to Cosmos Health's $5M push - Stock Titan
Cosmos Health (COSM) Unveils Innovative Curcumin Supplement for U.S. Market - GuruFocus
Cosmos Health expands AI integration across operations By Investing.com - Investing.com Australia
Cosmos Health plans Q2 U.S. launch of curcumin supplement By Investing.com - Investing.com Australia
Cosmos Health plans Q2 U.S. launch of curcumin supplement - Investing.com
A turmeric supplement with 39x absorption heads to the U.S. in Q2 - Stock Titan
Trending Industry Today: Cosmos Health Leads Gains In ETH-Holding Companies Stocks - Moomoo
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Cosmos Health expands AI integration across operations - Investing.com
Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30% - ACCESS Newswire
Record 2025 revenue and margin expansion at Cosmos Health (COSM) - Stock Titan
Cosmos Health Inc. 2025 Annual Report: Growth Strategy, Product Portfolio, and Global Healthcare Market Expansion - Minichart
Cosmos Health (COSM) Achieves Record Revenue and Significant Mar - GuruFocus
Cosmos 2025 10-K: $65.3M Revenue, $(0.63) EPS on net loss - TradingView
Cosmos Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cosmos Health (NASDAQ: COSM) expands pipeline, AI drug repurposing and equity funding - Stock Titan
Cosmos Health reports record revenue of $65.3 million in 2025 By Investing.com - Investing.com Australia
Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Con - ACCESS Newswire
Cosmos Health reports record revenue of $65.3 million in 2025 - Investing.com
Cosmos Health Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Cosmos Health receives third UAE order for 60,000 units By Investing.com - Investing.com Australia
Cosmos Health receives third UAE order for 60,000 units - Investing.com
Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units - ACCESS Newswire
A third UAE reorder lifts Cosmos Health product demand to 270,000 units - Stock Titan
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
| Siokas Grigorios | Chief Executive Officer |
Jan 06 '26 |
Buy |
0.54 |
133,953 |
72,000 |
6,850,724 |
| Siokas Grigorios | Chief Executive Officer |
Dec 19 '25 |
Buy |
0.49 |
88,314 |
43,000 |
6,716,771 |
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
0.00%
7.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):